Logo - springer
Slogan - springer

| Drug Safety - Case Reports

Drug Safety - Case Reports

Drug Safety - Case Reports

Editors: N. Joshi; S. McMillan

ISSN: 2198-977X (electronic version)

Journal no. 40800

Learn more about the metrics of this journal
  • Publishes case reports of individual and multiple patients experiencing adverse reactions to a wide range of medicinal products
  • Reports include overdose, abuse, misuse, occupational exposure and more
  • Also covers medication errors, off-label use and near-misses

Drug Safety - Case Reports is an online, open access journal specialising in the publication of case reports and case series relating to suspected adverse drug reactions.  As well as reports of any unintended or adverse effects following administration of a medicinal product (or products), the journal welcomes reports of cases involving `near misses' (for example, medication errors detected before harm is done) and cases involving the lack of efficacy of a therapeutic product.

Drug Safety - Case Reports offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles published may be accompanied by plain language summaries to assist patients, caregivers and others in their understanding. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) at an introductory price of US$1,095. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

Related subjects » Adis

Abstracted/Indexed in 

PubMedCentral, EMBASE, Google Scholar, CNKI, DOAJ, EBSCO Discovery Service, EBSCO TOC Premier, OCLC WorldCat Discovery Service, ProQuest ABI/INFORM, ProQuest Business Premium Collection, ProQuest Central, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    • Publishes case reports of individual and multiple patients experiencing adverse reactions to a wide range of medicinal products.
    • Reports include overdose, abuse, misuse, occupational exposure and more.
    • Also covers medication errors, off-label use and near-misses.
    • Articles published in Drug Safety - Case Reports may be accompanied by plain language summaries to assist patients, caregivers and others in their understanding.

    Drug Safety - Case Reports is an online, open access journal specialising in the publication of case reports and case series relating to suspected adverse drug reactions.  As well as reports of any unintended or adverse effects following administration of a medicinal product (or products), the journal welcomes reports of cases involving `near misses' (for example, medication errors detected before harm is done) and cases involving the lack of efficacy of a therapeutic product.

    Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety - Case Reports may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. All enhanced features are peer reviewed to the same high standard as the article itself.

    Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) at an introductory price of US$1,095.  Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CCBY-NC) License, which does not permit commercial re-use of the article.

  • Submit Online
  • Instructions for Authors

    Instructions for Authors

    Close

  • Conflict of Interest form (doc, 84 kB)
  • Compliance with Ethical Policies
  • Copyright Information

    Copyright Information

    Close

    Copyright and Licence Agreement

    Open Access Drug Safety - Case Reports is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, go to: http://creativecommons. org/licenses/by-nc/4.0

    Journal ownership: Springer International Publishing Switzerland

    Copyright of articles: © The Author(s)

Alerts for this journal

 

Get the table of contents of every new issue published in Drug Safety - Case Reports.